get a key
steadybase-$ person Chellie Tunan
nameChellie Tunan
roleCFO
company RxSight Inc. RXST
linkedin none on file
contactnot published
filingsnone on file
quotes
On a sequential basis, SG&A expenses rose 5% from $14.9 million in the third quarter of 2022, due primarily to a major professional meeting, increased travel, and increased incentive compensation on higher revenues.

Mar 6, 2023 / CFO / receipt, needs a key / Chellie Tunan, CFO | earnings call 2023-03-06 | transcript ba0c1bd4-227e-4502-bc16-75e0ab684fe1 | chars 5478-5693 | segment 5

SG&A expenses rose 79% to $58.7 million, due primarily to investments made to expand the spies and scope of our commercial organization, resumption of in-person, ophthalmic meetings, and increased travel.

Mar 6, 2023 / CFO / receipt, needs a key / Chellie Tunan, CFO | earnings call 2023-03-06 | transcript ba0c1bd4-227e-4502-bc16-75e0ab684fe1 | chars 6960-7164 | segment 6

steadybase-$